On January 16, 2025, the highly anticipated “2024 Deloitte China Technology Fast 50” list was officially released. Enzyme Products, thanks to its continuous innovation and rapid development in the field of biopharmaceuticals and technology, has once again been honored by being selected for the “2024 Deloitte Shenzhen Technology Fast 20” list, successfully entering the ranks of the “China 50” !
Deloitte’s Technology Fast 60 program is now in its 20th year. This year’s theme is ” Innovation and Quality, Beyond Growth,” which emphasizes that companies should focus more on innovation and high-quality development, strengthen the application of AI technology and talent development , balance short-term and long-term interests, and promote sustainable development.
1. The High-Quality Development Process of Enzyme Products
The company is a leading enterprise in the field of green bioactive raw materials in China. With synthetic biology technology at its core, it has built the most complete multidisciplinary biomanufacturing platform in China, integrating R&D and industrialization. It possesses full-cell synthesis, enzyme catalysis, and chemical synthesis technologies and mass production capabilities . Based on the complementary advantages of multiple technologies, the company has achieved efficiency, quality, cost, and production capacity advantages that are difficult to obtain with traditional synthesis technologies, providing support for the continued commercial success of its products.
Enzyme Product Shenzhen R&D Center
The company is also one of the earliest synthetic biology companies to introduce artificial intelligence (AI) technology into enzyme engineering. As early as 2020, the company established an AI team in the UK to conduct AI-assisted enzyme design and modification. In recent years, the company has systematically deployed resources around the core elements of AI—algorithms, computing power, and data— establishing the ReAI4Bio platform. To date, it has built more than 50 AI models, applied for nearly 30 AI invention patents, built its own computing center with more than 10 supercomputing servers, a supercomputing power of 200 trillion calculations per second, a self-built protein database with more than 5.2 billion entries, and a high-quality private enzyme database with more than 300,000 entries . AI is now applied in the company’s internal R&D scenarios. Based on wet experimental data of typical industrial enzymes, combined with deep learning models, and using a combination of wet and dry datasets, the model is iteratively trained to ultimately achieve precise enzyme screening and modification.
Enzyme Products UK AI R&D Center
The company boasts a research and development team of over 200 people, with more than 50% holding master’s degrees or higher. The company places great emphasis on a balance between management and technology, particularly the matching of its scientific team and industrialization expert team. Dozens of scientists, professors, doctoral supervisors, and high-level national and local talents from globally renowned pharmaceutical companies, universities, and research institutions are engaged in full-time research at the company. The industrialization expert team has over 20 years of practical experience in chemical engineering, fermentation engineering, enzyme catalysis reaction engineering, purification engineering, and plant design . This well-balanced combination of front-end and back-end talent helps the company overcome industrialization barriers more quickly.
Thanks to its excellent talent and experience reserves, Enzyme Products established a production base in Baiyin, Gansu in 2021, achieving a production capacity of ten tons of active ingredients for cosmetics and pharmaceuticals. In 2022, it started construction of a smart factory in Zhuhai, which was completed and put into operation in the second half of 2023. In 2023, it started preparations for a thousand-ton-level industrial base, and in 2024, it was confirmed that the project would be located in the Wengyuan Innovation Raw Material Industrial Park in Shaoguan. The project has a total investment of approximately RMB 1.1 billion, a planned construction area of 70,000 square meters, an annual output of 1,000 tons of green active ingredients, and an annual output value of over RMB 2 billion. After the project is put into operation, it will become the largest biosynthetic GLP-1 raw material and peptide base in China .
Enzyme products are green active raw materials
The company ranks among the top international companies in terms of R&D investment, scale, and output value. It has undertaken a number of key provincial and municipal R&D projects, applied for nearly 200 invention patents, and received more than ten national and local titles, including National Specialized and Innovative Small Giant Enterprise, National High-tech Enterprise, Guangdong Provincial Postdoctoral Innovation Practice Base, Shenzhen Peacock Team, Shenzhen Potential Unicorn Enterprise, Zhuhai Innovation and Entrepreneurship Team, and Gansu Provincial Specialized and Innovative Small and Medium-sized Enterprise. It was also recognized as one of the Top 50 High-Growth Enterprises in China and one of the Top 20 High-Growth Enterprises in Shenzhen in 2024, won the Harvard Business Review High-Energy Innovation Team Award in 2023, and was named one of the Top 100 High-Growth Enterprises in Shenzhen in 2022.
2. Regarding the “Deloitte China Technology Fast 50”
Deloitte is a leading global professional services firm. The Deloitte Technology Fast 50 program was founded in Silicon Valley, USA in 1995 and entered China in 2005, and is held annually in dozens of countries and regions around the world. The “Deloitte China Technology Fast 50” program, now in its 20th year, is dedicated to discovering rapidly growing and continuously innovative high-tech companies and is hailed by the industry as a “benchmark for global high-growth companies.”
The list has featured many industry leaders over the years, including Tencent, Alibaba, Baidu, JD.com, SMIC, WuXi AppTec, ByteDance, Apple, Microsoft, Google, Tesla, and Nvidia. Companies typically enter the list at an early stage, earning it the reputation as a “cradle of great technology companies.”